Research programs
Clinical research
“AO Spine is the only truly global spine community. We endeavor to unite regions all over the world and motivate universal research participation.”
Dino Samartzis, Past Chairperson, AO Spine Research Commission
The AO Spine Knowledge Forums (KFs) are the engines of AO Spine clinical research. They perform evidence-based research and develop AO Spine classifications, staging of the disease, treatment guidelines, and outcome measures.
The KFs meet regularly to discuss research, assess the best evidence for current practices, and formulate clinical studies to advance their field of spine expertise.
KF Tumor
Leading the way in spine oncology research—an international network of spine oncology centers committed to collaborative prospective multicenter research.
KF Deformity
KF Spinal Cord Injury (SCI)
KF Trauma and Infection
KF Degenerative
Preclinical research
“Our mission is to advance orthopedic patient care through innovative research and development.”
Martin Stoddart, AO Research Institute Davos Program Head
AO Spine performs preclinical research in collaboration with the AO Research Institute Davos (ARI). The pre-clinical outcomes are brought to the AO Spine Knowledge Forums for clinical evaluation.
AO Spine’s preclinical research focus is on Regenerative Orthopaedics and postoperative spinal infection.
Currently, AO Spine sponsors three projects with the AO Research Institute Davos Regenerative Orthopaedics program focused on spine:
Functional therapy for annulus fibrosus (AF) repair to reduce the disc re-herniation risk;
Evaluation of hyaluronan-based hydrogels for nucleus pulposus (NP) repair; and
Impact of the immune status on the susceptibility to postoperative spine infection.
Annulus fibrosus defect organ culture model. A and B, cutting of operation window; C, creating of the defect through the AF and partial NP using a biopsy punch; D, filling of the defect with biomimetic hydrogel and/or functional cells; E and F, suturing of the operation window.
Postoperative surgical site infection is one of the most frequent and serious complications after spine surgery. Biomarkers that describe the patient’s immune status would be instrumental to evaluate the personal risk of each patient and take appropriate preventative measures.
AO Spine aims to identify parameters with significant variations between patients with postsurgical infection and patients with no complications. These parameters can be analyzed at a global scale to evaluate the individual patient’s infection risk, for precision medical care.